Eli Lilly & Co. (LLY) Tops Q1 EPS by 21c, Raises FY EPS Guidance
Tweet
Share
E-mail
Get Alerts LLY Hot Sheet
Price: $724.87 -1%
EPS Growth %: +51.9%
Financial Fact:
Asset impairments, restructuring, and other special charges: 45.5M
Today's EPS Names:
WF, CWBC, GLTO, More
EPS Growth %: +51.9%
Financial Fact:
Asset impairments, restructuring, and other special charges: 45.5M
Today's EPS Names:
WF, CWBC, GLTO, More
Join SI Premium – FREE
Eli Lilly & Co. (NYSE: LLY) reported Q1 EPS of $1.34, $0.21 better than the analyst estimate of $1.13. Revenue for the quarter came in at $5.7 billion versus the consensus estimate of $5.49 billion.
GUIDANCE:
Eli Lilly & Co. sees FY2018 EPS of $5.10-$5.20, versus the consensus of $4.88.
For earnings history and earnings-related data on Eli Lilly & Co. (LLY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Intel slides in afterhours trading as Q1 revenue misses, Q2 outlook falls short
- Intel (INTC) tops Q1 EPS by 3c; misses on guidance
- Edwards Lifesciences (EW) Tops Q1 EPS by 2c; offers guidance
Create E-mail Alert Related Categories
Earnings, Guidance, Hot Earnings, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
